Evidence map›Paper›PMID 32904407›Full record

ArticleCJC open2020

Impact of the Pandemic on NonInfected Cardiometabolic Patients: A Survey in Countries of Latin America-Rationale and Design of the CorCOVID LATAM Study.

Ricardo Lopez Santi, Daniel Leonardo Piskorz, Manlio F Marquez, Cristhian Ramirez Ramos, Nicolás Federico Renna, Martin Ibarrola, Fernando Stuardo Wyss, Adrián Naranjo Dominguez, Gonzalo Emanuel Perez, Juan María Farina and 8 more

Abstract read
In one paragraph

Article in CJC open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Effect of Vitamin DMicroorganisms · 2023
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Ricardo Lopez SantiDivision of Cardiology, Hospital Italiano de La Plata, Buenos Aires, Argentina.
Daniel Leonardo PiskorzCardiovascular Institute of the Rosario British Sanatorium, Santa Fe, Argentina.
Manlio F MarquezInstituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México.
Cristhian Ramirez RamosCentro de Medicina del Ejercicio y Rehabilitación Cardíaca S.A CEMDE, Medellín, Colombia.
Nicolás Federico RennaDepartment of Cardiology, Hospital Español de Mendoza, Mendoza, Argentina.
Martin IbarrolaCardiovascular Center BV, Buenos Aires, Argentina.
Fernando Stuardo WyssServicios y Tecnología Cardiovascular de Guatemala S.A., Guatemala City, Guatemala.
Adrián Naranjo DominguezInstituto de Cardiología y Cirugía Cardiovascular, La Habana, Cuba.
Gonzalo Emanuel PerezDivision of Cardiology, Clínica Olivos, Buenos Aires, Argentina.
Juan María FarinaDivision of Cardiology, Clínica Olivos, Buenos Aires, Argentina.
Ezequiel ForteCENDIC, Centro Diagnóstico Cardiovascular, Entre Ríos, Argentina.
Jorge Paul Juarez LlocllaHospital de Apoyo II Santa Rosa, Piura, Perú.
Emma Flores de EspinalHospital Nacional San Juan De Dios, Cardiovascular Division, San Miguel City, El Salvador.
Adriana Puente BarraganCentro Médico Nacional 20 de Septiembre ISSSTE, Ciudad de México, México.
Mauro Gabriel RuiseCardio CCV Clínica Yunes, Santiago del Estero, Argentina.
Diego DelgadoDivision of Cardiology, University of Toronto, Toronto, Ontario, Canada.
Adrian BaranchukDepartment of Medicine, Queen's University, Kingston, Ontario, Canada.
CorCOVID LATAM Study Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe first case of coronavirus 2019 (COVID-19) in Latin America was detected on February 26th, 2020, in Brazil. Later, in June, the World Health Organization announced that the focus of the outbreak had shifted to Latin America, where countries already had poor control of indicators of noncommunicable diseases (NCDs). Concerns about coronavirus infection led to a reduced number of visits and hospitalizations in patients with NCDs, such as cardiovascular disease, diabetes, and cancer. There is a need to determine the impact of the COVID-19 pandemic on patients who have cardiometabolic diseases but do not have clinical evidence of COVID-19 infection.

methodsThe CorCOVID LATAM is a cross-sectional survey of ambulatory cardiometabolic patients with no history or evidence of COVID-19 infection. The study will be conducted by the Interamerican Society of Cardiology. An online survey composed of 38 questions using Google Forms will be distributed to patients of 13 Latin American Spanish-speaking countries from June 15th to July 15th, 2020. Data will be analyzed by country and regions. Seven clusters of questions will be analyzed: demographics, socioeconomic and educational level, cardiometabolic profile, lifestyle and habits, body-weight perception, medical follow-up and treatments, and psychological symptoms.

resultsFinal results will be available upon completion of the study.

conclusionsThe present study will provide answers regarding the impact of the COVID-19 pandemic on noninfected cardiometabolic patients. Data on this topic are scarce, as it is an unprecedented threat, without short-term solutions.

Identifiers

PMID32904407
PMCPMC7455154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.